Stem-Cell Derived Exosomal microRNAs as Biomarkers and Therapeutics for Pediatric Cardiovascular Disease
Aaron H. Wasserman,
No information about this author
Bana Abolibdeh,
No information about this author
Reema Hamdan
No information about this author
et al.
Current Treatment Options in Cardiovascular Medicine,
Journal Year:
2025,
Volume and Issue:
27(1)
Published: April 9, 2025
In
recent
years,
several
pre-clinical
studies
have
demonstrated
the
therapeutic
potential
of
stem
cell-derived
exosomes
in
treatment
cardiovascular
disease
(CVD).
Here,
we
evaluate
their
as
biomarkers
for
detection
and
monitoring
CVD,
with
a
particular
focus
on
pediatric
heart
disease.
Exosomes
isolated
from
cell
sources,
including
mesenchymal
cells
(MSCs)
pluripotent
(PSCs),
benefit
function,
inflammatory
responses,
angiogenesis
injured
diseased
hearts.
These
carry
variety
cargo,
such
proteins,
lipids,
nucleic
acids.
However,
majority
contain
non-coding
RNA
molecules.
Review
existing
literature
RNAs
relationship
to
CVD
suggests
that
containing
microRNAs
(miRNAs)
can
serve
promising
due
presence
circulation,
ease
isolation,
potential.
are
especially
screening
diagnostic
tools
early
congenital
Language: Английский
LncRNA ZFAS1/miR-186-5p axis is involved in oxidative stress inhibition of myocardial ischemia-reperfusion injury by targeting BTG2
Yi Xiang,
No information about this author
Hui Shan,
No information about this author
Hao Nie
No information about this author
et al.
Expert Review of Clinical Immunology,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 12
Published: Oct. 4, 2024
To
probe
the
involvement
of
long
noncoding
RNA
zinc
finger
antisense
1
(ZFAS1)/microRNA
(miR)-186-5p
axis
in
inhibiting
oxidative
stress
myocardial
ischemia-reperfusion
injury
(MIRI)
by
targeting
B-cell
translocation
gene
2
(BTG2).
Language: Английский
Advantages and disadvantages of targeting senescent endothelial cells in cardiovascular and cerebrovascular diseases based on small extracellular vesicles
Wen Ma,
No information about this author
Tingyuan Zhou,
No information about this author
Songling Tang
No information about this author
et al.
Expert Opinion on Therapeutic Targets,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 15
Published: Oct. 30, 2024
With
the
growth
of
aging
population,
age-related
diseases
have
become
a
heavy
global
burden,
particularly
cardiovascular
and
cerebrovascular
(CVDs).
Endothelial
cell
(EC)
senescence
constitutes
an
essential
factor
in
development
CVDs,
prompting
increased
focus
on
strategies
to
alleviate
or
reverse
EC
senescence.
Language: Английский